Apkarian AV et al., Human brain mechanisms of pain perception and regulation in health and disease.
European Journal of Pain 9 (2005) 463–484.

Geha P Y and Apkarian AV., Brain Imaging Findings in Neuropathic Pain.
Current Pain and Headache Reports 2005, 9:184–188.

Fields RD., Beyond the Neuron Doctrine.
Scientific American Mind June/July 2006 p 21–27.

Stewart et al., Lost Productivity Time and Cost Due to Common Pain Conditions in the US Workforce.
JAMA November 12, 2003–Vol. 290, No. 18 p 2443–2454.

Thernstrom M., Pain — The Disease
New York Times, December 16, 2001.

Apkarian AV., Functional imaging of pain: new insights regarding the role of the cerebral cortex in human pain perception.
Semin Neurosci 1995; 7:279–293.

Arnold LM et al., A Double-Blind, Multicenter Trial Comparing Duloxetine With Placebo in the Treatment of Fibromyalgia Patients With or Without Major Depressive Disorder.
Arth & Rheum Vol. 50, No. 9, September 2004, pp 2974–2984.

Arnold et al., A randomized, double-blind, placebo-controlled trial of
Duloxetine in the treatment of women with fibromyalgia with or without
major depressive disorder.
Pain 119 (2005) 5–15.

Crofford LJ et al., Pregabalin for the Treatment of Fibromyalgia Syndrome.
Arth & Rheum Vol. 52, No. 4, April 2005, pp 1264–1273.

Caldwell JR et al., Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized placebo-controlled double-blind trial and open-label extension trial.
J Pain Symptom Manage 2002; 23: 278–291.

Caldwell JR et al., Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal anti-inflammatory drugs: a double-blind, randomized multicenter placebo-controlled trial.
J Rheumatol 1999; 26: 862–869.

Roth SH et al., Around-the-clock, controlled release oxycodone therapy for osteoarthritis-related pain.
Arch Intern Med 2000; 160: 853–860.